Figure 1.
Relationship between bone marrow and PB blast percentage measured by MFC in patients with AML. PB and BMA blast percentage measured by MFC are plotted for all sample pairs (A; N = 724), first sample pair for each patient (B; n = 477), pairs for which PB and BMA samples were obtained on the same day (C; n = 323), pairs obtained from patients within 30 days before HCT (D; n = 32), pairs obtained within 90 days after HCT (E; n = 64), and pairs for which BMA blasts were <5% by both flow cytometry and morphology (F; n = 209). Spearman correlation coefficient and linear regression correlation coefficient are shown for each analysis.

Relationship between bone marrow and PB blast percentage measured by MFC in patients with AML. PB and BMA blast percentage measured by MFC are plotted for all sample pairs (A; N = 724), first sample pair for each patient (B; n = 477), pairs for which PB and BMA samples were obtained on the same day (C; n = 323), pairs obtained from patients within 30 days before HCT (D; n = 32), pairs obtained within 90 days after HCT (E; n = 64), and pairs for which BMA blasts were <5% by both flow cytometry and morphology (F; n = 209). Spearman correlation coefficient and linear regression correlation coefficient are shown for each analysis.

Close Modal

or Create an Account

Close Modal
Close Modal